Federico Lussana

24PUBLICATIONS
74CO-AUTHORS
Liquid biopsiesCardiology (incl. cardiovascular diseases)OrthopaedicsElectrochemical energy storage and conversionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Nov 12, 2025
Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study.

M Delia, D Lazzarotto, S Imbergamo

|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

|Jun 02, 2025
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study.

Gianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni

|Apr 03, 2025
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Federico Lussana, Chiara F Magnani, Stefania Galimberti

|Feb 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.

Renato Bassan, Sabina Chiaretti, Irene Della Starza

|May 21, 2024
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.

Marta Castelli, Maria Caterina Micò, Anna Grassi

Pageof 4

Frequent Collaborators

9 joint publications

Alessandro Rambaldi

6 joint publications

Orietta Spinelli

5 joint publications

Anna Candoni

4 joint publications

Massimiliano Bonifacio